Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
Bristol-Myers Squibb
Thierry André; Elena Elez; Heinz-Josef Lenz; Lars Henrik Jensen; Yann Touchefeu; Eric Van Cutsem; Rocio Garcia-Carbonero; David Tougeron; Guillermo Ariel Mendez; Michael Schenker; Christelle de la Fouchardiere; Maria Luisa Limon; Takayuki Yoshino; Jin Li; Jose Luis Manzano Mozo; Laetitia Dahan; Giampaolo Tortora; Myriam Chalabi; Eray Goekkurt; Maria Ignez Braghiroli; Rohit Joshi; Timucin Cil; Francine Aubin; Elvis Cela; Tian Chen; Ming Lei; Lixian Jin; Steven I Blum; Sara Lonardi